CFTR and cystic fibrosis: While the increasing use of CFTR modulators has helped treat the underlying cause of CF and increased life expectancy, CFTR modulators have not yet shown sustained reductions in prevalence rates of CF pathogen infections, including NTM (25, –, 29).